CompletedPhase 1NCT01911455

Study of Acamprosate in Fragile x Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Craig Erickson, MD
Children's Hospital Medical Center, Cincinnati
Intervention
acamprosate(drug)
Enrollment
46 enrolled
Eligibility
5-23 years · All sexes
Timeline
20132018

Study locations (2)

Collaborators

Rush University Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01911455 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials